Can preference scores for discrete states be used to derive preference scores for an entire path of events? An application to prenatal diagnosis

Medical Decision Making

Volumn 17, Issue 1, 1997, Pages 42-55

  Kuppermann, Miriam ^a,b,e   Shiboski, Stephen ^b   Feeny, David ^c   Elkin, Eric P ^d   Washington, A Eugene ^a,b  

^a Med Effectiveness Res Ctr D   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

multiple regression; patient preferences; prenatal diagnosis; standard gamble; utility measurement; visual analog scaling

Indexed keywords

AMNIOCENTESIS; ARTICLE; CHORION VILLUS SAMPLING; DECISION MAKING; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PATIENT ATTITUDE; TREATMENT PLANNING;

EID: 0031016613     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X9701700105     Document Type: Article

References (33)

1. Mehrez A, Gafni A. Quality-adjusted life years, utility theory, and healthy-year equivalents. Med Decis Making. 1989;9: 142-9.
2. Mehrez A, Gafni A. The healthy-years equivalents: how to measure them using the standard gamble approach. Med Decis Making. 1991;11:140-6.
3. Mehrez A, Gafni A. Healthy-years equivalents versus quality-adjusted life years: in pursuit of progress. Med Decis Making. 1993;13:287-92.
4. Gafni A, Birch S. Searching for a common currency: critical appraisal of the scientific basis underlying European harmonization of the measurement of health-related quality of life (EuroQol). Health Policy. 1993;23:219-28.
5. Gafni A, Birch S, Mehrez A. Economics, health and health economics: HYEs (healthy-years equivalent) versus QALYs (quality-adjusted live-years). J Health Econ. 1993;12:325-39.
6. Buckingham K. A note on HYE (healthy years equivalent). J Health Econ. 1993;12:301-9.
7. Culyer AJ, Wagstaff A. QALYs (quality-adjusted life-years) versus HYEs (healthy years equivalents). J Health Econ. 1993;12: 311-23.
8. Johannesson M, Pliskin JS, Weinstein MC. Are healthy-years equivalents an improvement over quality-adjusted life years? Med Decis Making. 1993;13:281-6.
9. Feeny DH, Barr RU, Furlong W, Torrance GW, Weitzman S. Quality of life of the treatment process in pediatric oncology: an approach to measurement. In: Osoba D (ed). Effect of Cancer on Quality of Life. Boca Raton, FL: CRC Press, 1991: 73-88.
10. Feeny DH, Torrance GW. Incorporating utility-based quality-of-life assessment measures in clinical trials. Med Care. 1989; 27:8190-8204.
11. Bass EB, Steinberg EP, Pitt HA, et al. Comparison of the rating scale and the standard gamble in measuring patient preferences for outcomes of gallstone disease. Med Decis Making. 1994;14:307-14.
12. Drummond MF, Stoddart GL, Torrance GW. Methods for Economic Evaluation of Health Care Programs. Oxford, U.K.: Oxford University Press, 1987.
13. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care. 1989;5:559-75.
14. Beck JR, Pauker SC. The Markov process in medical prognosis. Med Decis Making. 1983;3:419-58.
15. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13:322-38.
16. Deaton A, Muellbauer J. Economics and Consumer Behavior. Cambridge, U.K.; New York: Cambridge University Press, 1980.
17. Cornes R. Duality and Modern Economics. Cambridge, U.K.; New York: Cambridge University Press, 1992.
18. Browning M. A simple nonadditive preference structure for models of household behavior over time. J Polit Econ. 1991; 99:607-37.
19. NICHD National Registry for Amniocentesis Study Group. Midtrimester amniocentesis for prenatal diagnosis: safety and accuracy. JAMA. 1976;236:1471-6.
20. Rhoads GG, Jackson LG, Schlesselman SE, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med. 1989; 320:609-17.
21. Heckerling PS, Verp MS. Amniocentesis or chorionic villus sampling for prenatal genetic testing: a decision analysis. J Clin Epidemiol. 1991;44:657-70.
22. Von Neumann J, Morgenstern D. Theory of Games and Economic Behavior. 3rd ed. New York: John Wiley, 1954.
23. Furlong W, Feeny DH, Torrance GW, Barr R, Horsman J. Guide to Design and Development of Health-State Utility Instrumentation. Centre for Health Economics and Policy Analysis Working Paper Series #90-9. Hamilton, Ontario, Canada: McMaster University, 1990.
24. Llewelyn-Thomas H, Sutherland HJ, Tibshirani R, Ciampi A, Till JE, Boyd NF. The measurement of patients' values in medicine. Med Decis Making. 1982;2:449-62.
25. Conover WJ. Practical Nonparametric Statistics. New York: John Wiley & Sons, 1980.
26. Breiman L, Friedman JH, Olshen R, Stone CJ. Classification and Regression Trees. Belmont, CA: Wadsworth, 1984.
27. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York: Chapman and Hall, 1993.
28. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
29. Becker RA, Chambers JM, Wilks AR. The New S Language. Pacific Grove, CA: Wadsworth &, Brooks/Cole, 1988.
30. Torrance GW. Measurement of health state utilities for economic appraisal: a review. J Health Econ. 1986;5:1-30.
31. Cleveland WS, Devlin SJ. Locally weighted regression: an approach to regression analysis by local fitting. J Am Statist Assoc. 1988;83:596-610.
32. Richardson J, Hall J, Salkeld G. The measurement of utility in multiphase health states. Int J Technol Assess. 1996;12:151-62.
33. Fischer GW. Utility models for multiple objective decisions: do they accurately represent human preferences? Decis Sci. 1979;10:451-79.